Trials / Completed
CompletedNCT03028948
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
Internet Intervention for Sun Protection and Skin Self-check Behaviors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 485 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
Detailed description
PRIMARY OBJECTIVES: I. To evaluate the impact of the interactive tailored website (ITW) versus usual care on skin self-examination (SSE) and sun protection behaviors among individuals diagnosed with melanoma. SECONDARY OBJECTIVES: I. To examine mediators of the impact of the intervention. The effects of the intervention on SSE and sun protection behaviors will be mediated by melanoma knowledge, self-efficacy for SSE and sun protection behaviors, perceived benefits of SSE and sun protection behaviors, perceived barriers to SSE and sun protection behaviors, and perceived controllability of melanoma. TERTIARY OBJECTIVES: I. To examine moderators of the impact of the intervention. To evaluate whether ITW effects are moderated by the following factors: time since diagnosis, disease stage, age, sex, income, education, Internet experience, distress about melanoma, worry about recurrence, and evaluation and usage of the ITW. OUTLINE: Phase I: Patients review draft website content materials in a semi-structured format and provide feedback via open- and closed-ended questions for the development, testing, and finalization of ITW. Phase II: Patients are randomized into 1 of 2 arms. ARM I: Patients access ITW and complete each module over 30-40 minutes. ARM II: Patients receive usual care and are then offered ITW. All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
Conditions
- Stage 0 Skin Melanoma
- Stage I Skin Melanoma
- Stage IA Skin Melanoma
- Stage IB Skin Melanoma
- Stage II Skin Melanoma
- Stage IIA Skin Melanoma
- Stage IIB Skin Melanoma
- Stage IIC Skin Melanoma
- Stage III Skin Melanoma
- Stage IIIA Skin Melanoma
- Stage IIIB Skin Melanoma
- Stage IIIC Skin Melanoma
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Internet-Based Intervention | Access ITW |
| OTHER | Questionnaire Administration | Ancillary studies |
| OTHER | Survey Administration | Ancillary studies |
Timeline
- Start date
- 2017-01-13
- Primary completion
- 2020-08-29
- Completion
- 2020-08-29
- First posted
- 2017-01-23
- Last updated
- 2026-01-14
- Results posted
- 2023-02-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03028948. Inclusion in this directory is not an endorsement.